SCHEMBL21806005

SCHEMBL21806005

CCCCCCCCC1(C(N)=O)CCCCC1C

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 3/20 0.36
AKT1 P31749 10/20 0.35
BCHE P06276 1/20 0.35
EPHX1 P07099 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22534527 0.86 NAAA (0.37) NAAAAKT1
SCHEMBL30468892 0.80 EPHX1 (0.34) EPHX1
SCHEMBL11359306 0.74 CYP1A2 (0.34) AKT1
SCHEMBL9299912 0.74 AKT1 (0.34) AKT1EPHX1
SCHEMBL5645678 0.73 NAAA (0.39) NAAAAKT1
SCHEMBL5646098 0.73 NAAA (0.39) NAAAAKT1
SCHEMBL5650450 0.73 NAAA (0.39) NAAAAKT1
SCHEMBL5644160 0.73 NAAA (0.39) NAAAAKT1
SCHEMBL5645017 0.73 NAAA (0.39) NAAAAKT1
SCHEMBL5646432 0.73 NAAA (0.39) NAAAAKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3596053-B1 FARNESOID X RECEPTOR AGONISTS AND USES THEREOF ORGANOVO INC (US) 2023-08-16 EP disclosed
EP-3852736-A1 FARNESOID X RECEPTOR AGONISTS AND USES THEREOF Metacrine, Inc. (US) 2021-07-28 EP disclosed
WO-2020061118-A1 FARNESOID X RECEPTOR AGONISTS AND USES THEREOF METACRINE, INC. (US) 2020-03-26 WO disclosed
WO-2020061117-A1 FARNESOID X RECEPTOR AGONISTS AND USES THEREOF METACRINE, INC. (US) 2020-03-26 WO disclosed
WO-2020061116-A1 FARNESOID X RECEPTOR AGONISTS AND USES THEREOF METACRINE, INC. (US) 2020-03-26 WO disclosed